Prostate Cancer Clinical Trial
— IMPPACTOfficial title:
Mindfulness-based Therapy Group Intervention for Couple's Dealing With Sexual Dysfunction After Prostate-cancer Treatment
NCT number | NCT03177707 |
Other study ID # | IMPPACT |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 24, 2017 |
Est. completion date | April 30, 2018 |
Verified date | October 2019 |
Source | Vancouver Prostate Centre |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
With improvements in detection and treatment of prostate cancer (PCa), more men than ever are living with side effects from PCa treatment; most distressingly, treatment side effects include problems with sexual functioning (e.g. erectile dysfunction, climacturia, inorgasmia). This study aims to develop a mindfulness-based group treatment for couples with sexual functioning complaints post-PCa treatment. Couples will be invited to a four-session mindfulness-based treatment group. Pre- and post-treatment outcomes (e.g., distress, sexual functioning/enjoyment, relationship satisfaction, treatment adherence) will assess feasibility and effectiveness of this novel treatment for couple's sexual lives after PCa.
Status | Completed |
Enrollment | 28 |
Est. completion date | April 30, 2018 |
Est. primary completion date | April 30, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility |
Inclusion Criteria: - Currently in a relationship that has lasted longer than 1 year - Both members of the couple are at least 19 years of age or older - Both members of the couple are able to speak and read English (to date, all of the treatment material is delivered in English) - (At least) one member of the couple has a history of prostate cancer diagnosis - The same member of the couple underwent radical prostatectomy for the treatment of his prostate cancer - Both members of the couple are willing and able to comply with all study procedures (including committing to daily homework over the 4-week period of the treatment program) and be available for the duration of the study - Both members of the couple provide signed and dated informed consent form Exclusion Criteria: - The individual who was treated with prostate cancer received androgen deprivation therapy or radiation therapy to treat their prostate cancer. - Have a current health condition (e.g., severe cardiovascular health problems, unmanaged diabetes mellitus), physical disabilities, or mental health issues (e.g., severe anxiety, depression) that would interfere with self- or partnered-sexual activities, or the individual's ability to attend group sessions or complete home assignments |
Country | Name | City | State |
---|---|---|---|
Canada | Vancouver Prostate Centre | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
Vancouver Prostate Centre |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Treatment mechanisms factors: Five Facets of Mindfulness questionnaire Short form | Five Facets of Mindfulness questionnaire; Short form (Bohlmeijer, E., P. M. ten Klooster, et al., 2011), which is a validated, 24-item measure of different aspects of attentiveness. | Change from baseline to post-intervention (5 weeks) | |
Other | Treatment mechanisms factors: Five Facets of Mindfulness questionnaire Short form | Five Facets of Mindfulness questionnaire; Short form (Bohlmeijer, E., P. M. ten Klooster, et al., 2011), which is a validated, 24-item measure of different aspects of attentiveness. | Change from post-intervention (5 weeks) to 6-month follow up | |
Other | Treatment mechanisms factors: Expectations for treatment | Expectations for treatment. A 4-item questionnaire, designed for and used in our approved mindfulness-based treatment study for women with provoked vestibulodynia | Change from baseline to post-intervention (5 weeks) | |
Other | Treatment mechanisms factors: Expectations for treatment, | Expectations for treatment. A 4-item questionnaire, designed for and used in our approved mindfulness-based treatment study for women with provoked vestibulodynia | Change from post-intervention (5 weeks) to 6-month follow up | |
Other | Treatment mechanisms factors: Time since prostate cancer treatment | This is a single-item, face-valid question asking participants to indicate time since prostate cancer treatment. Responses will be cross-validated by comparing against partner response and also information gathered from their chart, if they were recruited through the Sexual Health Service. | Change from baseline to post-intervention (5 weeks) | |
Other | Treatment mechanisms factors: Time since prostate cancer treatment | This is a single-item, face-valid question asking participants to indicate time since prostate cancer treatment. Responses will be cross-validated by comparing against partner response and also information gathered from their chart, if they were recruited through the Sexual Health Service. | Change from post-intervention (5 weeks) to 6-month follow up | |
Other | Treatment mechanisms factors: Penile Rehabilitation Aids Use | This questionnaire asks participants about their/their partner's use of penile rehabilitation aids, and their perception of these treatment usefulness will be asked. | Change from baseline to post-intervention (5 weeks) | |
Other | Treatment mechanisms factors: Penile Rehabilitation Aids Use | This questionnaire asks participants about their/their partner's use of penile rehabilitation aids, and their perception of these treatment usefulness will be asked. | Change from post-intervention (5 weeks) to 6-month follow up | |
Other | Treatment mechanisms factors: Mindfulness Practice | This is a questionnaire designed by the experimenters to assess the amount of daily mindfulness practice. Participants will indicate the number of minutes they spent practicing each day. This log will be completed as a separate, online questionnaire that participants will access daily. Participants have the option of completing a paper-version of this log, which they will give to the Study Coordinator each week. | Change from baseline to post-intervention (5 weeks) | |
Other | Treatment mechanisms factors: Mindfulness Practice | This is a questionnaire designed by the experimenters to assess the amount of daily mindfulness practice. Participants will indicate the number of minutes they spent practicing each day. This log will be completed as a separate, online questionnaire that participants will access daily. Participants have the option of completing a paper-version of this log, which they will give to the Study Coordinator each week. | Change from post-intervention (5 weeks) to 6-month follow up | |
Primary | Sexual correlates: Self-reported sexual functioning | Depending on sexual orientation and gender, individuals will complete either (1) International Index of Erectile Functioning (heterosexual men), International Index of Erectile Functioning for Men who have sex with men (gay men), or Female Sexual Functioning Index (female partners) | Change from baseline to post-intervention (5 weeks) | |
Primary | Sexual correlates: Self-reported erectile functioning | Depending on sexual orientation and gender, individuals will complete either (1) International Index of Erectile Functioning (heterosexual men), International Index of Erectile Functioning for Men who have sex with men (gay men), or Female Sexual Functioning Index (female partners) | Change from post-intervention (5 weeks) to 6-month follow up | |
Primary | Sexual correlates: GMSEX | GMSEX (Lawrance & Byers, 1992). The GMSEX is a 5-item measure of distress related to sexual functioning with one's partner. | Change from baseline to post-intervention (5 weeks) | |
Primary | Sexual correlates: GMSEX | GMSEX (Lawrance & Byers, 1992). The GMSEX is a 5-item measure of distress related to sexual functioning with one's partner. | Change from post-intervention (5 weeks) to 6-month follow up | |
Primary | Sexual correlates: Sexual activity scale | This is a questionnaire developed by the study lead that asks individual to rate the frequency of times that they engaged in a range of sexual activities over 3 time-periods: (a) ever, (b) since their/their partner's prostate cancer surgery, and (c) in the past 4 weeks. | Change from baseline to post-intervention (5 weeks) | |
Primary | Sexual correlates: Sexual activity scale | This is a questionnaire developed by the study lead that asks individual to rate the frequency of times that they engaged in a range of sexual activities over 3 time-periods: (a) ever, (b) since their/their partner's prostate cancer surgery, and (c) in the past 4 weeks. | Change from post-intervention (5 weeks) to 6-month follow up | |
Primary | Sexual correlates: Adapted dyadic adjustment scale | Adapted dyadic adjustment scale (A-DAS; Sharpley & Cross, 1982). The A-DAS is a validated, 7-item measure that assesses relationship adjustment. | Change from baseline to post-intervention (5 weeks) | |
Primary | Sexual correlates: Adapted dyadic adjustment scale | Adapted dyadic adjustment scale (A-DAS; Sharpley & Cross, 1982). The A-DAS is a validated, 7-item measure that assesses relationship adjustment. | Change from post-intervention (5 weeks) to 6-month follow up | |
Secondary | mental and health-related quality of life indices: Hospital Anxiety and Depression Scale | Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). The HADS is a validated, 14-item measure of depression and anxiety.. | Change from baseline to post-intervention (5 weeks) | |
Secondary | mental and health-related quality of life indices: Hospital Anxiety and Depression Scale | Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). The HADS is a validated, 14-item measure of depression and anxiety.. | Change from post-intervention (5 weeks) to 6-month follow up | |
Secondary | mental and health-related quality of life indices: UCLA Prostate Cancer Index | UCLA Prostate Cancer Index (Litwin, Hays, Fink, Ganz, Leake, & Brook, 1998). This is a 20-item measure that assesses health-related quality of life indices specific to common side effects of prostate cancer treatment. | Change from baseline to post-intervention (5 weeks) | |
Secondary | mental and health-related quality of life indices: UCLA Prostate Cancer Index | UCLA Prostate Cancer Index (Litwin, Hays, Fink, Ganz, Leake, & Brook, 1998). This is a 20-item measure that assesses health-related quality of life indices specific to common side effects of prostate cancer treatment. | Change from post-intervention (5 weeks) to 6-month follow up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |